In re Lantus Direct Purchaser Antitrust Litigation

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MASSACHUSETTS In re LANTUS DIRECT PURCHASER CIVIL ACTION ANTITRUST LITIGATION NO. 16-12652-JGD MEMORANDUM OF DECISION AND ORDER ON DEFENDANT’S MOTION TO DISMISS January 10, 2018 DEIN, U.S.M.J. I. INTRODUCTION Plaintiffs, FWK Holdings, LLC and Cesar Castillo, Inc., are purchasers of the insulin glargine products Lantus and Lantus SoloSTAR, which are used in the treatment of Type I and Type II diabetes. They have brought a purported class action on behalf of themselves and all others similarly situated against Sanofi-Aventis U.S. LLC (“Sanofi”),…